The mission of our clinical research is to foster discoveries in the novel therapies of inflammatory bowel diseases, gastrointestinal and pancreatic cancer, hepatitis, and other gastrointestinal disorders. Our doctors are committed to providing the best care and management of diseases while testing cutting-edge therapies.

Back to full list of clinical trials

Ongoing clinical trials for hepatitis B: Actively recruiting


Condition:

Hepatitis B

Study title:

Hepatitis B Research Network

Description of study:

This is an NIH study following patients with HBV.  The purpose of the study is to follow the natural history of HBV and to create a database for future treatment protocols.

Basic eligibility criteria:

Adults with chronic HBV and currently not on treatment.

Principal Investigator:

Ray Chung, MD

Contact:

Cara Foley; 617-726-0161


Condition:

Hepatitis B

Study title:

Hepatitis B Research Network

Description of study:

This is an NIH treatment study following patients with HBV.  The purpose of the study is to determine the efficacy of treatment of adults in the immune tolerant phase of chronic HBV infection with entecavir plus interferon.

Basic eligibility criteria:

Adults with chronic HBV who are currently not on treatment and are in the immune tolerant phase.
Principal Investigator:

Ray Chung, MD

Contact:

Cara Foley; 617-726-0161


Condition:

Hepatitis B

Study title:

Hepatitis B Research Network

Description of study: This is an NIH treatment study following patients with HBV.  The purpose of the study is to determine the efficacy of treatment of adults in the immune active phase of chronic HBV infection with combination therapy with tenofovir plus interferon versus tenofovir monotherapy.

Basic eligibility criteria:

Adults with chronic HBV who are currently not on treatment and are in the immune active phase

Principal Investigator:

Ray Chung, MD

Contact:

Cara Foley; 617-726-0161


Condition:

Hepatitis B

Study title:

Hepatitis B Research Network

Description of study: This is an NIH study following patients co-infected with HBV and HIV. The purpose of the study is to establish non-invasive ways to assess liver injury and to examine the role HIV treatment may have on the suppression of HBV.

Basic eligibility criteria:

Adults co-infected with HBV and HIV who are currently being treated for HIV.
Principal Investigator:

Ray Chung, MD

Contact:

Cara Foley; 617-726-0161